Establishment and validation of a liquid-phase blocking ELISA for the detection of antibodies elicited by the foot-and-mouth disease virus A/ASIA/Sea-97 lineage

References

• Barnett PV, Statham RJ, Vosloo W, Haydon DT. 2003. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine. 21:3240–3248. doi:10.1016/S0264-410X(03)00219-6
   PubMed Web of Science ®Google Scholar
• Diaz-San Segundo F, Medina GN, Stenfeldt C, Arzt J, de Los Santos T. 2017. Foot-and-mouth disease vaccines. Vet Microbiol. 206:102–112. doi:10.1016/j.vetmic.2016.12.018
   PubMed Web of Science ®Google Scholar
• Doel TR, Baccarini PJ. 1981. Thermal stability of foot-and-mouth disease virus. Arch Virol. 70:21–32. doi:10.1007/BF01320790
   PubMed Web of Science ®Google Scholar
• Golding SM, Hedger RS, Talbot P. 1976. Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease. Res Vet Sci. 20:142–147. doi:10.1016/S0034-5288(18)33445-3
   PubMed Web of Science ®Google Scholar
• Hamblin C, Barnet IT, Crowther JR. 1986b. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application. J Immunol Methods. 93:123–129. doi:10.1016/0022-1759(86)90442-4
   PubMed Web of Science ®Google Scholar
• Hamblin C, Barnet IT, Hedger RS. 1986a. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus I. development and method of ELISA. I. Development and method of ELISA. J Immunol Methods. 93:115–121. doi:10.1016/0022-1759(86)90441-2
   PubMed Web of Science ®Google Scholar
• Hendriksen CFM. 2002. Refinement Reduction, and Replacement of Animal use for Regulatory Testing: Current Best Scientific Practices for the Evaluation of Safety and Potency of Biologicals ILAR J. 43:S43–S48.
   Google Scholar
• Kang Y-L, Jeong J-Y, Choi H-Y, Zhang Y, Liu Y, Lee H-J, Choi J-C, Lee S-H, Lee B-J, Lee S-W, et al. 2018. Evaluation and optimization of a conventional SPCE for FMD post-vaccination monitoring. BMC Vet Res. 14:371. doi:10.1186/s12917-018-1686-7
   PubMed Web of Science ®Google Scholar
• Kärber G. 1931. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch Exp Pathol Pharmacol. 162:480–483. doi:10.1007/BF01863914
   Google Scholar
• Landis JR, Koch GG. 1977. The measurement of observer agreement for categorical data. Biometrics. 33:159–174. doi:10.2307/2529310
   PubMed Web of Science ®Google Scholar
• Lee G, Hwang J-H, Park J-H, Lee MJ, Kim B, Kim S-M. 2020. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage. Antiviral Res. 182:104920. doi:10.1016/j.antiviral.2020.104920
   PubMed Web of Science ®Google Scholar
• Mackay DK, Bulunt AN, Rendle T, Davidson F, Ferris NP. 2001. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J Virol Methods. 97:33–48. doi:10.1016/S0166-0934(01)00333-0
   PubMed Web of Science ®Google Scholar
• Mandrekar JN. 2010. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 5:1315–1316. doi:10.1097/JTO.0b013e3181ec173d
   PubMed Web of Science ®Google Scholar
• Maradei E, La Torre J, Robiolo B, Esteves J, Seki C, Pedemonte A, Lglesias M, D’Alola R, Mattion N. 2008. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Vaccine. 26:6577–6586. doi:10.1016/j.vaccine.2008.09.033
   PubMed Web of Science ®Google Scholar
• Niedbalski W. 2004. Comparison of different ELISA methods for the detection of antibodies against foot-and-mouth disease virus (FMDV) type O. Bull Vet Inst Pulawy. 48:5–9.
   Google Scholar
• [OIE] World Organization for Animal Health. 2021. Manual of diagnostic tests and vaccines for terrestrial animal. In: Chapter 3.1.8. foot-and-mouth disease (Infection with foot and mouth disease virus). http://oie.int/en/what-we-do/standards/code-and-manuals/terrestrial-manual-online-access/ (updated 24 Nov 2021).
   Google Scholar
• Paiba GA, Anderson J, Paton DJ, Soldan AW, Alexandersen S, Corteyn M, Wilsden G, Hamblin P, Mackey DKJ, Donaldson AI. 2004. Validation of a foot-and-mouth disease antibody screening solid-phase competition ELISA (SPCE). J Virol Methods. 115:145–158. doi:10.1016/j.jviromet.2003.09.016
   PubMed Web of Science ®Google Scholar
• Parida S. 2009. Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev Vaccines. 8:347–365. doi:10.1586/14760584.8.3.347
   PubMed Web of Science ®Google Scholar
• Park M-Y, Han YJ, Choi E-J, Kim H, Pervin R, Shin W, Kwon D, Kim JM, Pyo HM. 2021. Post-vaccination monitoring to assess foot-and-mouth disease immunity at population level in Korea. Front Vet Sci. 8:673820. doi:10.3389/fvets.2021.673820
   PubMed Web of Science ®Google Scholar
• Park S-H, Lee S-Y, Kim J-S, Kim A-Y, Park S-Y, Lee J-H, Lee M, Kim H, Lee S-I, Kang N-Y, et al. 2021. Scale-up production of type O and A foot-and-mouth disease bivalent vaccine and its protective efficacy in pigs. Vaccines (Basel). 9:586. doi:10.3390/vaccines9060586
   PubMed Web of Science ®Google Scholar
• Paton DJ, Reeve R, Capozzo AV, Ludi A. 2019. Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory. Vaccine. 37:5515–5524. doi:10.1016/j.vaccine.2019.07.102
   PubMed Web of Science ®Google Scholar
• Periolo OH, Seki C, Grigera PR, Robiolo B, Fernandez ME, D’Aloia R, La Torre JL. 1993. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina. Vaccine. 11:754–760. doi:10.1016/0264-410X(93)90261-U
   PubMed Web of Science ®Google Scholar
• Robiolo B, La Torre J, Maradei E, Beascoechea CP, Perez A, Seki C, Smitsaart E, Fondevila N, Palma E, Goris N, et al. 2010. Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests. Vaccine. 28:6235–6241. doi:10.1016/j.vaccine.2010.07.012
   PubMed Web of Science ®Google Scholar
• Sheskin DJ. 2004. Test 28: The Pearson product-moment correlation coefficient. In: Handbook of parametric and nanoparametric statistical procedures. 3rd ed. Boca Raton: CRC press; p. 945–1025.
   Google Scholar
• Spearman C. 1908. The method of “right and wrong cases” (constant stimuli) without gauss’s formula. Br J Psychol. 2:227–242.
   Google Scholar
• Van Maanen C, Terpstra C. 1989. Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J Immunol Methods. 124:111–119. doi:10.1016/0022-1759(89)90192-0
   PubMed Web of Science ®Google Scholar
• Van Stralen KJ, Jager KJ, Zoccali C, Dekker FW. 2008. Agreement between methods. Kidney Int. 74:1116–1120. doi:10.1038/ki.2008.306
   PubMed Web of Science ®Google Scholar
• Veerasami M, Singanallur NB, Thirumeni N, Rana SK, Shanmugham R, Ponsekaran S, Muthukrishnan M, Villuppanoor SA. 2008. Serotyping of foot-and-mouth disease virus by antigen capture-ELISA using monoclonal antibodies and chicken IgY. New Microbiol. 31:549–554.
   PubMed Web of Science ®Google Scholar
• Wong CL, Yong CY, Hk O, Ho KL, Tan WS. 2020. Advances in the diagnosis of foot-and-mouth disease. Front Vet Sci. 7:477. doi:10.3389/fvets.2020.00477
   PubMed Web of Science ®Google Scholar
• Zweig MH, Campbell G. 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 39:561–577.
   Google Scholar